94 related articles for article (PubMed ID: 8430273)
1. Modification of reticuloendothelial function by muramyl dipeptide-encapsulated liposomes in jaundiced rats treated with biliary decompression.
Ding JW; Andersson R; Hultberg B; Soltesz V; Bengmark S
Scand J Gastroenterol; 1993 Jan; 28(1):53-62. PubMed ID: 8430273
[TBL] [Abstract][Full Text] [Related]
2. Reticuloendothelial system phagocytic function in obstructive jaundice and its modification by a muramyl dipeptide analogue.
Pain JA; Collier DS; Ritson A
Eur Surg Res; 1987; 19(1):16-22. PubMed ID: 3792414
[TBL] [Abstract][Full Text] [Related]
3. The influence of biliary obstruction and sepsis on reticuloendothelial function in rats.
Ding JW; Andersson R; Norgren L; Stenram U; Bengmark S
Eur J Surg; 1992 Mar; 158(3):157-64. PubMed ID: 1356455
[TBL] [Abstract][Full Text] [Related]
4. Obstructive jaundice impairs reticuloendothelial function and promotes bacterial translocation in the rat.
Ding JW; Andersson R; Soltesz V; Willén R; Bengmark S
J Surg Res; 1994 Aug; 57(2):238-45. PubMed ID: 8028331
[TBL] [Abstract][Full Text] [Related]
5. Effect of biliary decompression on reticuloendothelial function in jaundiced rats.
Ding JW; Andersson R; Stenram U; Lunderquist A; Bengmark S
Br J Surg; 1992 Jul; 79(7):648-52. PubMed ID: 1643476
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of bacterial translocation in obstructive jaundice by muramyl tripeptide phosphatidylethanolamine in the rat.
Ding JW; Andersson R; Soltesz VL; Pärsson H; Johansson K; Wang W; Bengmark S
J Hepatol; 1994 Jun; 20(6):720-8. PubMed ID: 7930471
[TBL] [Abstract][Full Text] [Related]
7. Biliary obstruction reduces hepatic killing and phagocytic clearance of circulating microorganisms in rats.
Hoshino S; Sun Z; Uchikura K; Tsugane K; Ceppa E; Bulkley GB; Klein AS
J Gastrointest Surg; 2003; 7(4):497-506. PubMed ID: 12763407
[TBL] [Abstract][Full Text] [Related]
8. Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice.
Fogler WE; Wade R; Brundish DE; Fidler IJ
J Immunol; 1985 Aug; 135(2):1372-7. PubMed ID: 4008926
[TBL] [Abstract][Full Text] [Related]
9. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
Tanaka A; Nagao S; Nagao R; Kotani S; Shiba T; Kusumoto S
Infect Immun; 1979 May; 24(2):302-7. PubMed ID: 457275
[TBL] [Abstract][Full Text] [Related]
11. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
12. Effects of biliary drainage in obstructive jaundice on microcirculation, phagocytic activity, and ultrastructure of the liver in rats.
Matsumoto Y; Niimoto S; Katayama K; Hirose K; Yamaguchi A; Torigoe K
J Hepatobiliary Pancreat Surg; 2002; 9(3):360-6. PubMed ID: 12353147
[TBL] [Abstract][Full Text] [Related]
13. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
Daemen T; Veninga A; Dijkstra J; Scherphof G
J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the functions of the reticuloendothelial and protease-antiprotease systems after intraperitoneal injection of zymosan in rats.
Deng X; Sun Z; Lasson A; Wang X; Andersson R
Eur J Surg; 1998 Aug; 164(8):605-15. PubMed ID: 9720938
[TBL] [Abstract][Full Text] [Related]
16. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
17. Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.
Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):603-9. PubMed ID: 2506020
[TBL] [Abstract][Full Text] [Related]
18. Improvement of normothermic rat liver ischemia/reperfusion by muramyl dipeptide.
Cursio R; Gugenheim J; Panaia-Ferrari P; Lasfar A; Tovey M; Chastanet S; Saint-Paul MC; Ferré C; Mouiel J
J Surg Res; 1998 Dec; 80(2):339-44. PubMed ID: 9878335
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function.
Scott-Conner CE; Grogan JB
J Surg Res; 1994 Aug; 57(2):316-36. PubMed ID: 8028341
[TBL] [Abstract][Full Text] [Related]
20. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
